Open an account

Somnigroup International

TPX · NYSE

$63.94+$1.14 (+1.82%)TodayMarket closed ·
Prev close $62.80

TPX analyst rating

This isn't available right now. Refresh to try again.

The case for and against

Updated Feb 19, 2025

Bull case

Tempur Sealy International Inc. is experiencing a positive shift in sales trends, with fourth-quarter forecasts appearing more favorable than the previous three quarters, highlighted by a year-over-year sales growth of 1.4% in FQ1 and an estimated same-store sales increase of 3.0%. The company is anticipated to achieve substantial earnings growth, with projected earnings per share (EPS) estimated to reach between $5.50 and $6.00 by 2027, alongside the potential realization of significant synergies of approximately $300 million in EBITDA over the next 5-10 years from the Mattress Firm acquisition. Furthermore, the expected recovery in industry demand, combined with strategic operational improvements and strong market positioning, supports a robust outlook for Tempur Sealy's future growth and profitability.

Bear case

Tempur Sealy International Inc is facing a challenging financial outlook due to several factors impacting its market position and profitability. The company's projections for sales growth are several points lower than industry expectations for 2025, signaling potential weakness in consumer demand and competitive pressures, especially within the memory foam category. Furthermore, rising costs in raw materials, particularly oil and chemicals, pose a risk to the company's margins, while operational inefficiencies stemming from their manufacturing processes could further exacerbate financial performance.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.